
Halper Sadeh LLC is investigating whether shareholders of Organon, XOMA Royalty, RE/MAX Holdings, and Soleno Therapeutics received fair deals in their recent sales transactions. The firm alleges insiders may have received financial benefits not available to ordinary shareholders and that deal terms could limit better competing offers. Shareholders are encouraged to contact the firm for legal advice and potential claims to seek higher compensation or additional disclosures. This investigation highlights concerns over shareholder rights in major corporate sales.